USP General Chapter Open for Public Comment

Article

The chapter is open for comment until Nov. 30, 2019.

USP General Chapter <1108> Assays to Evaluate Fragment Crystallizable (Fc)-Mediated Effector Function is now open for public comment online in the Pharmacopeial Forum 45(5) until Nov. 30, 2019.

The new general chapter was created to give users guidance regarding the selection, development, and validation of Fc function assays, including the measurement of low-affinity interactions observed with Fc gamma receptors (FcγR) and the impact of glycosylation on antibody effector function.

The Fc region plays a key role in regulating the immune system’s responses by modulating the actions of antibodies. FcγR, which are membrane-bound proteins,control and mediate the communication between immunoglobulin antibodies and the immune system, for example, and studies have demonstrated that these specific receptors play multiple roles in conferring immunity against influenza viruses, making them a focus for vaccine development efforts.

The chapter can be accessed for free at https://www.uspnf.com/pharmacopeial-forum.

Source: USP

 

Recent Videos
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Adam Sherlock, CEO of Qinecsa Solutions
Related Content
© 2025 MJH Life Sciences

All rights reserved.